No impact of protein phosphatases on connexin 43 phosphorylation in ischemic preconditioning

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 295, Issue 5, 2008, Pages

  Totzeck, Andreas ^a   Boengler, Kerstin ^a   Van De Sand, Anita ^a   Konietzka, Ina ^a   Gres, Petra ^a   Garcia Dorado, David ^b   Heusch, Gerd ^a   Schulz, Rainer ^a  

^a UNIVERSITY HOSPITAL ESSEN   (Germany)

^b HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

Author keywords

Cardioprotection; Ischemia reperfusion

Indexed keywords

CONNEXIN 43; PHOSPHOPROTEIN PHOSPHATASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; HEART INFARCTION; HEART LEFT VENTRICLE; HEART MUSCLE ISCHEMIA; MITOCHONDRION; NONHUMAN; PRIORITY JOURNAL; PROTEIN INTERACTION; PROTEIN PHOSPHORYLATION; SARCOLEMMA;

ANIMALS; CALCINEURIN; CONNEXIN 43; DISEASE MODELS, ANIMAL; GAP JUNCTIONS; ISCHEMIC PRECONDITIONING, MYOCARDIAL; MITOCHONDRIA, HEART; MYOCARDIAL INFARCTION; MYOCARDIAL REPERFUSION INJURY; MYOCARDIUM; PHOSPHORYLATION; PROTEIN BINDING; PROTEIN PHOSPHATASE 1; PROTEIN PHOSPHATASE 2; SWINE; SWINE, MINIATURE;

EID: 57049097684     PISSN: 03636135     EISSN: 15221539     Source Type: Journal    
DOI: 10.1152/ajpheart.00456.2008     Document Type: Article

References (41)

1. Ai X, Pogwizd SM. Connexin 43 downregulation and dephosphorylation in nonischemic heart failure is associated with enhanced colocalized protein phosphatase type 2A. Circ Res 96: 54-63, 2005.
2. Armstrong SC, Gao W, Lane JR, Ganote CE. Protein phosphatase inhibitors calyculin A and fostriecin protect rabbit cardiomyocytes in late ischemia. J Mol Cell Cardiol 30: 61-73, 1998.
3. Armstrong SC, Hoover DB, Shivell LC, Ganote CE. Preconditioning of isolated rabbit cardiomyocytes: no evident separation of induction, memory and protection. J Mol Cell Cardiol 29: 2285-2298, 1997.
4. Axelsen LN, Stahlhut M, Mohammed S, Larsen BD, Nielsen MS, Holstein-Rathlou NH, Andersen S, Jensen ON, Hennan JK, Kjolbye AL. Identification of ischemia-regulated phosphorylation sites in connexin43: A possible target for the antiarrhythmic peptide analogue rotigaptide (ZP123). J Mol Cell Cardiol 40: 790-798, 2006.
5. Beardslee MA, Lerner DL, Tadros PN, Laing JG, Beyer EC, Yamada KA, Kleber AG, Schuessler RB, Saffitz JE. Dephosphorylation and intracellular redistribution of ventricular connexin43 during electrical uncoupling induced by ischemia. Circ Res 87: 656-662, 2000.
6. Boengler K, Dodoni G, Ruiz-Meana M, Cabestrero A, Rodriguez-Sinovas A, Garcia-Dorado D, Gres P, Di Lisa F, Heusch G, Schulz R. Connexin 43 in cardiomyocyte mitochondria and its increase by ischemic preconditioning. Cardiovasc Res 67: 234-244, 2005.
7. Chen HH, Baty CJ, Maeda T, Brooks S, Baker LC, Ueyama T, Gursoy E, Saba S, Salama G, London B, Stewart AF. Transcription enhancer factor-1-related factor-transgenic mice develop cardiac conduction defects associated with altered connexin phosphorylation. Circulation 110: 2980-2987, 2004.
8. 2+ handling in a calcineurin transgenic model of heart failure. Cardiovasc Res 54: 105-116, 2002.
9. Cohen P. The structure and regulation of protein phosphatases. Annu Rev Biochem 58: 453-508, 1989.
10. Cohen PT. Novel protein serine/threonine phosphatases: variety is the spice of life. Trends Biochem Sci 22: 245-251, 1997.
11. Cohen PT. Protein phosphatase 1-targeted in many directions. J Cell Sci 115: 241-256, 2002.
12. Duthe F, Plaisance I, Sarrouilhe D, Herve JC. Endogenous protein phosphatase 1 runs down gap junctional communication of rat ventricular myocytes. Am J Physiol Cell Physiol 281: C1648-C1656, 2001.
13. Fenton RA, Dickson EW, Dobson JG Jr. Inhibition of phosphatase activity enhances preconditioning and limits cell death in the ischemic/ reperfused aged rat heart. Life Sci 77: 3375-3388, 2005.
14. Garcia-Dorado D, Inserte J, Ruiz-Meana M, Gonzalez MA, Solares J, Julia M, Barrabés JA, Soler-Soler J. Gap junction uncoupler heptanol prevents cell-to-cell progression of hypercontracture and limits necrosis during myocardial reperfusion. Circulation 96: 3579-3586, 1997.
15. Heinzel FR, Luo Y, Li X, Boengler K, Buechert A, García-Dorado D, Di Lisa F, Schulz R, Heusch G. Impairment of diazoxide-induced formation of reactive oxygen species and loss of cardioprotection in connexin 43 deficient mice. Circ Res 97: 583-586, 2005.
16. Herve JC, Sarrouilhe D. Protein phosphatase modulation of the intercellular junctional communication: importance in cardiac myocytes. Prog Biophys Mol Biol 90: 225-248, 2006.
17. Hund TJ, Lerner DL, Yamada KA, Schuessler RB, Saffitz JE. Protein kinase Cepsilon mediates salutary effects on electrical coupling induced by ischemic preconditioning. Heart Rhythm 4: 1183-1193, 2007.
18. Ingebritsen TS, Cohen P. Protein phosphatases: properties and role in cellular regulation. Science 221: 331-338, 1983.
19. Jain SK, Schuessler RB, Saffitz JE. Mechanisms of delayed electrical uncoupling induced by ischemic preconditioning. Circ Res 92: 1138-1144, 2003.
20. Jalife J, Morley GE, Vaidya D. Connexins and impulse propagation in the mouse heart. J Cardiovasc Electrophysiol 10: 1649-1663, 1999.
21. Jeyaraman M, Tanguy S, Fandrich RR, Lukas A, Kardami E. Ischemia-induced dephosphorylation of cardiomyocyte connexin-43 is reduced by okadaic acid and calyculin A but not fostriecin. Mol Cell Biochem 242: 129-134, 2003.
22. Kwak BR, Jongsma HJ. Regulation of cardiac gap junction channel permeability and conductance by several phosphorylating conditions. Mol Cell Biochem 157: 93-99, 1996.
23. Laird DW. Connexin phosphorylation as a regulatory event linked to gap junction internalization and degradation. Biochim Biophys Acta 1711: 172-182, 2005.
24. Lampe PD, Lau AF. Regulation of gap junctions by phosphorylation of connexins. Arch Biochem Biophys 384: 205-215, 2000.
25. Li WE, Nagy JI. Connexin43 phosphorylation state and intercellular communication in cultured astrocytes following hypoxia and protein phosphatase inhibition. Eur J Neurosci 12: 2644-2650, 2000.
26. Liu Y, Yang XM, Iliodromitis EK, Kremastinos DT, Dost T, Cohen MV, Downey JM. Redox signaling at reperfusion is required for protection from ischemic preconditioning but not from a direct PKC activator. Basic Res Cardiol 103: 54-59, 2008.
27. Lo CW. Role of gap junctions in cardiac conduction and development: insights from the connexin knockout mice. Circ Res 87: 346-348, 2000.
28. Moreno AP, Lau AF. Gap junction channel gating modulated through protein phosphorylation. Prog Biophys Mol Biol 94: 107-119, 2007.
29. Papp R, Gonczi M, Kovacs M, Seprenyi G, Vegh A. Gap junctional uncoupling plays a trigger role in the antiarrhythmic effect of ischaemic preconditioning. Cardiovasc Res 74: 396-405, 2007.
30. Post H, Schulz R, Behrends M, Gres P, Umschlag C, Heusch G. No involvement of endogenous nitric oxide in classical ischemic preconditioning in swine. J Mol Cell Cardiol 32: 725-733, 2000.
31. Revel JP, Karnovsky MJ. Hexagonal array of subunits in intercellular junctions of the mouse heart and liver. J Cell Biol 33: C7-C12, 1967.
32. Rodriguez-Sinovas A, Boengler K, Cabestrero A, Gres P, Morente M, Ruiz-Meana M, Konietzka I, Miró E, Totzeck A, Heusch G, Schulz R, Garcia-Dorado D. Translocation of connexin 43 to the inner mitochondrial membrane of cardiomyocytes through the heat shock protein 90-dependent TOM pathway and its importance for cardioprotection. Circ Res 99: 93-101, 2006.
33. Saez JC, Berthoud VM, Branes MC, Martinez AD, Beyer EC. Plasma membrane channels formed by connexins: their regulation and functions. Physiol Rev 83: 1359-1400, 2003.
34. Schulz R, Gres P, Skyschally A, Duschin A, Belosjorow S, Konietzka I, Heusch G. Ischemic preconditioning preserves connexin 43 phosphorylation during sustained ischemia in pig hearts in vivo. FASEB J 17: 1355-1357, 2003.
35. Schulz R, Heusch G. Connexin 43 and ischemic preconditioning. Cardiovasc Res 62: 335-344, 2004.
36. Sohl G, Willecke K. Gap junctions and the connexin protein family. Cardiovasc Res 62: 228-232, 2004.
37. Solan JL, Lampe PD. Connexin phosphorylation as a regulatory event linked to gap junction channel assembly. Biochim Biophys Acta 1711: 154-163, 2005.
38. Sosinsky GE, Nicholson BJ. Structural organization of gap junction channels. Biochim Biophys Acta 1711: 99-125, 2005.
39. Weinbrenner C, Baines CP, Liu GS, Armstrong SC, Ganote CE, Walsh AH, Honkanen RE, Cohen MV, Downey JM. Fostriecin, an inhibitor of protein phosphatase 2A, limits myocardial infarct size even when administered after onset of ischemia. Circulation 98: 899-905, 1998.
40. Yeo M, Lin PS. Functional characterization of small CTD phosphatases. Methods Mol Biol 365: 335-346, 2007.
41. Yeo M, Lin PS, Dahmus ME, Gill GN. A novel RNA polymerase II C-terminal domain phosphatase that preferentially dephosphorylates serine 5. J Biol Chem 278: 26078-26085, 2003.